Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Wall Street Breakfast: Bigger Hikes Ahead?
12:16pm, Tuesday, 07'th Mar 2023 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Pfizer (PFE) or GSK: Who Will Get the First FDA Nod for RSV Jab?
12:02pm, Tuesday, 07'th Mar 2023
An FDA advisory committee recommended approving Pfizer's (PFE) and GSK's respective RSV vaccines for older adults. Currently, there are no RSV vaccines anywhere in the world.
Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
11:20am, Tuesday, 07'th Mar 2023 Zacks Investment Research
Style Box ETF report for DHS
High Yield Stock Watchlist: March 2023
10:00am, Tuesday, 07'th Mar 2023
There are 17 stocks on my high-yield watchlist for March 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory.
Where Pfizer Stands With Analysts
07:00pm, Monday, 06'th Mar 2023 Benzinga
Over the past 3 months, 14 analysts have published their opinion on Pfizer (NYSE:PFE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's
The 7 Best Dividend Stocks to Buy in March 2023
05:23pm, Monday, 06'th Mar 2023
Investors should hold dividend stocks in their portfolios. In fact, in times of volatility, these are some of the safest stocks to own for healthy cash inflows, meaningful capital gains, and attractiv
Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023
03:00pm, Monday, 06'th Mar 2023 Benzinga
Upgrades
Goldman Sachs upgraded the previous rating for iQIYI Inc (NASDAQ:IQ) from Neutral to Buy. iQIYI earned $0.14 in the fourth quarter, compared to $0.35 in the year-ago quarter. At the moment, t
What To Expect From Pfizer In The Post-COVID-19 Era
03:11am, Monday, 06'th Mar 2023
In Q4 2022, the company's revenue was $24.29 billion, up 1.9% from the last three months of 2021, despite a significant decrease in people's desire to vaccinate against COVID-19. According to the Wall
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?
12:38pm, Sunday, 05'th Mar 2023 The Motley Fool
Can Lumen Technologies, Moderna, Baxter International, and Pfizer recover this year?
Pfizer: Crucial Moment For Buyers At Its 52-Week Low
12:30pm, Sunday, 05'th Mar 2023 Seeking Alpha
Investors stampeded out of Pfizer stock this week, driving it to a 52-week low. Read more to see why we rate PFE stock a strong buy.
Run, Don't Walk: This Bull Trap Is About To End
11:07am, Sunday, 05'th Mar 2023 Seeking Alpha
While inflation has hurt overall economic prosperity, various sectors fared better than feared, holding up major indices. Click here to read more.
3 Ideal Dividend Buys From Fortune's World's Most Admired All Stars 2023
07:50am, Sunday, 05'th Mar 2023
Fortune Magazine February/March 2023 Issue listed 50 World's Most Admired (WMA) companies based on a poll of "some 3,760 corporate executives, directors, and securities analysts." Acclaim from the wid
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?
07:38am, Sunday, 05'th Mar 2023
Lumen's slowing growth, high debt, and dividend cut spooked the bulls. Moderna and Pfizer both face tough post-pandemic slowdowns.
Pfizer: Crucial Moment For Buyers At Its 52-Week Low
07:30am, Sunday, 05'th Mar 2023
Investors stampeded out of Pfizer stock this week, driving it to a 52-week low. A pivotal moment for investors emerged as they scrutinize the possible Seagen acquisition, presenting a golden buying op
5 Relatively Safe And Cheap Dividend Stocks To Invest In - March 2023
02:30pm, Saturday, 04'th Mar 2023 Seeking Alpha
In this article, we highlight 5 large-cap, relatively safe, dividend stocks that are offering large discounts to their historical norms. Click here to learn more.
